In mesenchymal tumors, circPOK regulates pro-proliferative and pro-angiogenic factors by acting as a coactivator of ILF2/3 upon ILF2/3 binding to the proximal promoter of II6 (Guarnerio et al., 2019). The gene discussed is ILF2; the disease is mesenchymal cell neoplasm.